Xponance’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $620K | Buy |
2,225
+527
| +31% | +$152K | ﹤0.01% | 922 |
|
|
2025
Q4 | $514K | Sell |
1,698
-367
| -18% | -$115K | ﹤0.01% | 939 |
|
|
2025
Q3 | $579K | Sell |
2,065
-68
| -3% | -$18.5K | ﹤0.01% | 915 |
|
|
2025
Q2 | $515K | Sell |
2,133
-1,075
| -34% | -$254K | ﹤0.01% | 940 |
|
|
2025
Q1 | $781K | Sell |
3,208
-17
| -0.5% | -$5.11K | 0.01% | 785 |
|
|
2024
Q4 | $1.06M | Buy |
3,225
+97
| +3% | +$32.9K | 0.01% | 703 |
|
|
2024
Q3 | $1.05M | Buy |
3,128
+330
| +12% | +$105K | 0.01% | 686 |
|
|
2024
Q2 | $764K | Sell |
2,798
-263
| -9% | -$76.5K | 0.01% | 769 |
|
|
2024
Q1 | $1.06M | Buy |
3,061
+327
| +12% | +$108K | 0.01% | 701 |
|
|
2023
Q4 | $883K | Sell |
2,734
-562
| -17% | -$176K | 0.01% | 719 |
|
|
2023
Q3 | $1.18M | Buy |
3,296
+135
| +4% | +$52.1K | 0.02% | 602 |
|
|
2023
Q2 | $1.2M | Buy |
3,161
+211
| +7% | +$85.9K | 0.02% | 607 |
|
|
2023
Q1 | $1.41M | Sell |
2,950
-9
| -0.3% | -$4.21K | 0.02% | 546 |
|
|
2022
Q4 | $1.24M | Buy |
2,959
+562
| +23% | +$227K | 0.02% | 569 |
|
|
2022
Q3 | $1M | Buy |
2,397
+312
| +15% | +$156K | 0.02% | 578 |
|
|
2022
Q2 | $1.03M | Sell |
2,085
-4,387
| -68% | -$2.28M | 0.02% | 562 |
|
|
2022
Q1 | $3.65M | Sell |
6,472
-6,376
| -50% | -$3.84M | 0.06% | 251 |
|
|
2021
Q4 | $9.71M | Buy |
12,848
+260
| +2% | +$195K | 0.15% | 115 |
|
|
2021
Q3 | $9.39M | Buy |
12,588
+7,102
| +129% | +$5.32M | 0.18% | 98 |
|
|
2021
Q2 | $3.54M | Sell |
5,486
-1,228
| -18% | -$747K | 0.07% | 243 |
|
|
2021
Q1 | $3.83M | Buy |
6,714
+1,352
| +25% | +$801K | 0.08% | 201 |
|
|
2020
Q4 | $3.13M | Buy |
5,362
+4,504
| +525% | +$2.57M | 0.07% | 235 |
|
|
2020
Q3 | $442K | Sell |
858
-34
| -4% | -$17.2K | 0.01% | 704 |
|
|
2020
Q2 | $403K | Buy |
+892
| New | +$394K | 0.01% | 702 |
|
Other funds holding BIO
VCM
VPM
AI
